Kent W. Mouw, M.D., Ph.D. is a radiation oncology physician-scientist at Dana Farber Cancer Institute and Brigham & Women’s Hospital, an Associate Professor of Radiation Oncology at Harvard Medical School, and an Associate Member of the Broad Institute of MIT and Harvard.  He obtained his medical and graduate degrees from the University of Chicago and completed radiation oncology residency at the Harvard Radiation Oncology Program and a post-doctoral research fellowship at Dana-Farber Cancer Institute.  Dr. Mouw oversees an NIH-funded basic and translational research laboratory that investigates the role of DNA repair and cell cycle pathway alterations in bladder cancer and other tumor types. He also provides radiation oncology care for patients with genitourinary malignancies at the Dana-Farber/Brigham & Women’s Cancer Center, where he is Co-Director of the Bladder Cancer Center.